XIIIth International Congress on Parkinson's Disease
Vancouver, Canada, July 24th - 28th, 1999

Dopamine Agonists

• Early ropinirole reduces dyskinesias
• Cabergoline

COMT Inhibitors

• Entacapone and Tolcapone
• Tolcapone's effect on mitochondria is reduced by serum protein

Etiology, Pathogenesis, and Neuroprotection

• Endogenous neurotoxins and neuroprotectants
• Pathophysiology of the basal ganglia in PD

Depression and Quality of Life

• Depression is a major determinant of quality of life in PD

New and Experimental Treatments

• New and Experimental Treatments
• Cannabinoids in parkinsonism

Meeting Reports Menu